Theriva Biologics Inc (AMEX:TOVX)
$ 1.47 -0.11 (-6.96%) Market Cap: 4.09 Mil Enterprise Value: -10.27 Mil PE Ratio: 0 PB Ratio: 0.16 GF Score: 30/100

Q1 2020 Synthetic Biologics Inc Earnings Call Transcript

May 05, 2020 / 08:30PM GMT
Release Date Price: $86.88 (+2.21%)
Operator

Good afternoon, and welcome to the Synthetic Biologics 2020 First Quarter Investor Conference Call.

At this time, I would like to turn the call over to Vincent Perrone, Director, Corporate Communications, at Synthetic Biologics. Please go ahead, Vincent.

Vincent I. Perrone
Synthetic Biologics, Inc. - Director of Corporate Communication

Thank you, Tayla, and good afternoon, everyone. Welcome to Synthetic Biologics' 2020 First Quarter Investor Conference Call. Today, I'm joined remotely by our Chief Executive and Financial Officer, Steven Shallcross; Dr. Michael Kaleko, Senior Vice President of Research and Development; and Dr. Vince Wacher, Head of Product and Corporate Development.

Synthetic Biologics issued a press release this afternoon which provided operational highlights and reported our financial results for the quarter ending March 31, 2020. The release can be found on the Investor Relations section of our website.

During our call today we'll provide an operational update on our GI- and microbiome-focused clinical programs

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot